Forex Today: Risk appetite smashes the dollar
|What you need to know on Wednesday, May 27th:
Risk-on led the way as investors welcomed news related to economic reopenings and developments around possible COVID-19 vaccines. The greenback fell against all of its major rivals while stocks jumped globally. US indexes reached levels that were last seen in March.
Novavax, a US biotech company, announced that it had started human trials of a COVID-19 vaccine, in Australia. Results are expected by July, where the next phase of testing should begin. Right now, there are twelve different vaccines being tested around the globe.
The EUR/USD pair flirted with the 1.1000 level but was unable to clear it.
The Pound soared amid rumours indicating progress in Brexit talks. According to the latest headlines, the EU is willing to shift its stance on fisheries when talks resume next week, potentially opening the doors for other concessions between both parts.
The USD/JPY pair remained lifeless for a fifth consecutive day as the market ignored safe-haven assets.
The AUD and the CAD run to fresh multi-week highs against the greenback, backed by the rally in equities.
By the end of the US session, news made the rounds indicating that the US is considering a range of sanctions on China amid Beijing’s pressure on Hong Kong. Earlier in the day, Trump’s advisor Kudlow said that the President is not concerned about the trade deal that’s intact for the moment. He added that Trump’s main concerns are more related to China’s responsibility on the coronavirus spread and Hong Kong.
Gold eased and settled at around $1,710.00 price zone amid the better market mood. Crude oil prices edged higher, amid shrinking supply and hopes on economic comebacks.
Cryptocurrencies Price Prediction: Bitcoin, Ripple & Monero – American Wrap 26 May
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.